Broadline

Pays: Union européenne

Langue: anglais

Source: EMA (European Medicines Agency)

Achète-le

Ingrédients actifs:

eprinomectin, fipronil, praziquantel, (S)-methoprene

Disponible depuis:

Boehringer Ingelheim Vetmedica GmbH

Code ATC:

QP54AA54

DCI (Dénomination commune internationale):

eprinomectin, fipronil, praziquantel, (S)-methoprene

Groupe thérapeutique:

Cats

Domaine thérapeutique:

Antiparasitic products, insecticides and repellents, Avermectins, Eprinomectin, combinations,

indications thérapeutiques:

For cats with, or at risk from mixed infestations by cestodes, nematodes and ectoparasites. The veterinary medicinal product is exclusively indicated when all three groups are targeted at the same time.EctoparasitesTreatment and prevention of infestations by fleas (Ctenocephalides felis). Elimination of fleas within 24 hours. One treatment prevents further infestations for at least one month.Prevention of environmental flea contamination by inhibiting the development of flea immature stages (eggs, larvae and pupae) for over a month.The product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).Treatment and prevention of infestations by ticks (Ixodes ricinus). Elimination of ticks within 48 hours. One treatment prevents further infestations for up to 3 weeks.Treatment of notoedric mange (Notoedres cati).CestodesTreatment of infestations with tapeworms (Dipylidium caninum, Taenia taeniaeformis, Echinococcus multilocularis, Joyeuxiella pasqualei (adult), and Joyeuxiella fuhrmanni (adult)).NematodesTreatment of infestations with gastrointestinal nematodes (L3, L4 larvae and adults of Toxocara cati, adults of Toxascaris leonina, L4 larvae and adults of Ancylostoma tubaeforme and Ancylostoma ceylanicum, and adults of Ancylostoma brazilienze).Treatment of infestations with feline lungworms (L3 larvae, L4 larvae and adults of Aelurostrongylus abstrusus, L4 larvae and adults of Troglostrongylus brevior).Treatment of infestations with vesical worms (Capillaria plica).Prevention of heartworm disease (Dirofilaria immitis larvae) for one month.

Descriptif du produit:

Revision: 10

Statut de autorisation:

Authorised

Date de l'autorisation:

2013-12-04

Notice patient

                                19
B. PACKAGE LEAFLET
20
PACKAGE LEAFLET
:
BROADLINE SPOT-ON SOLUTION FOR CATS < 2.5 KG
BROADLINE SPOT-ON SOLUTION FOR CATS 2.5–7.5 KG
1.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF
THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
RELEASE, IF DIFFERENT
Marketing authorisation holder:
Boehringer Ingelheim Vetmedica GmbH
55216 Ingelheim/Rhein
GERMANY
Manufacturer responsible for batch release:
Boehringer Ingelheim Animal Health France SCS
4 Chemin du Calquet,
31000 Toulouse
FRANCE
2.
NAME OF THE VETERINARY MEDICINAL PRODUCT
BROADLINE spot-on solution for cats < 2.5 kg
BROADLINE spot-on solution for cats 2.5–7.5 kg
3.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)
Each unit dose (applicator) delivers:
Volume of
unit dose (ml)
Fipronil
(mg)
(S)-methoprene
(mg)
Eprinomectin
(mg)
Praziquantel
(mg)
Cats <2.5 kg
0.3
24.9
30.0
1.20
24.9
Cats 2.5-7.5 kg
0.9
74.7
90.0
3.60
74.7
Excipient: Butylhydroxytoluene (E321) 1 mg/ml.
Spot-on solution.
4.
INDICATIONS
For cats with, or at risk from mixed infestations by cestodes,
nematodes and ectoparasites. The
veterinary medicinal product is exclusively indicated when all three
groups are targeted at the same
time.
Ectoparasites
-
Treatment and prevention of infestations by fleas (
_Ctenocephalides felis)_
. Elimination of fleas
within 24 hours. One treatment prevents further infestations for at
least one month.
-
Prevention of environmental flea contamination by inhibiting the
development of flea immature
stages (eggs, larvae and pupae) for over a month.
-
The product can be used as part of a treatment strategy for the
control of flea allergy dermatitis
(FAD).
-
Treatment and prevention of infestations by ticks (
_Ixodes ricinus)_
. Elimination of ticks within
48 hours. One treatment prevents further infestations for up to 3
weeks.
-
Treatment of notoedric mange (
_Notoedres cati_
).
21
Cestodes
-
Treatment of infestations with tapeworms (
_Dipylidium caninum_
,
_Taenia taeniaeformis_
,
_Echinococcus multilocularis_
,
_Joyeuxiella pasq
                                
                                Lire le document complet
                                
                            

Résumé des caractéristiques du produit

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
BROADLINE spot-on solution for cats < 2.5 kg
BROADLINE spot-on solution for cats 2.5-7.5 kg
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCES:
Each unit dose applicator delivers:
Volume of
unit dose (ml)
Fipronil
(mg)
(S)-methoprene
(mg)
Eprinomectin
(mg)
Praziquantel
(mg)
Cats <2.5 kg
0.3
24.9
30.0
1.20
24.9
Cats 2.5–7.5 kg
0.9
74.7
90.0
3.60
74.7
EXCIPIENTS:
Butylhydroxytoluene (E321) 1 mg/ml.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Spot-on solution.
Clear colourless to yellow to red/brown solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For cats with, or at risk from mixed infestations by cestodes,
nematodes and ectoparasites. The
veterinary medicinal product is exclusively indicated when all three
groups are targeted at the same
time.
Ectoparasites
-
Treatment and prevention of infestations by fleas (
_Ctenocephalides felis)_
. Elimination of fleas
within 24 hours. One treatment prevents further infestations for at
least one month.
-
Prevention of environmental flea contamination by inhibiting the
development of flea immature
stages (eggs, larvae and pupae) for over a month.
-
The product can be used as part of a treatment strategy for the
control of flea allergy dermatitis
(FAD).
-
Treatment and prevention of infestations by ticks (
_Ixodes ricinus)_
. Elimination of ticks within
48 hours. One treatment prevents further infestations for up to 3
weeks.
-
Treatment of notoedric mange (
_Notoedres cati_
).
Cestodes
-
Treatment of infestations with tapeworms (
_Dipylidium caninum_
,
_Taenia taeniaeformis_
,
_Echinococcus multilocularis_
_, Joyeuxiella pasqualei _
(adult), and
_ Joyeuxiella fuhrmanni (_
adult
_))_
.
3
Nematodes
-
Treatment of infestations with gastrointestinal nematodes (L3, L4
larvae and adults of
_Toxocara _
_cati_
, adults of
_Toxascaris leonina,_
L4 larvae and adults of
_Ancylostoma tubaeforme 
                                
                                Lire le document complet
                                
                            

Documents dans d'autres langues

Notice patient Notice patient bulgare 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation bulgare 17-10-2019
Notice patient Notice patient espagnol 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation espagnol 17-10-2019
Notice patient Notice patient tchèque 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation tchèque 17-10-2019
Notice patient Notice patient danois 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation danois 17-10-2019
Notice patient Notice patient allemand 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation allemand 17-10-2019
Notice patient Notice patient estonien 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation estonien 17-10-2019
Notice patient Notice patient grec 08-04-2020
Notice patient Notice patient français 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation français 17-10-2019
Notice patient Notice patient italien 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation italien 17-10-2019
Notice patient Notice patient letton 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation letton 17-10-2019
Notice patient Notice patient lituanien 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation lituanien 17-10-2019
Notice patient Notice patient hongrois 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation hongrois 17-10-2019
Notice patient Notice patient maltais 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation maltais 17-10-2019
Notice patient Notice patient néerlandais 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation néerlandais 17-10-2019
Notice patient Notice patient polonais 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation polonais 17-10-2019
Notice patient Notice patient portugais 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation portugais 17-10-2019
Notice patient Notice patient roumain 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation roumain 17-10-2019
Notice patient Notice patient slovaque 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation slovaque 17-10-2019
Notice patient Notice patient slovène 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation slovène 17-10-2019
Notice patient Notice patient finnois 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation finnois 17-10-2019
Notice patient Notice patient suédois 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation suédois 17-10-2019
Notice patient Notice patient norvégien 08-04-2020
Notice patient Notice patient islandais 08-04-2020
Notice patient Notice patient croate 08-04-2020
Rapport public d'évaluation Rapport public d'évaluation croate 17-10-2019

Afficher l'historique des documents